Efficacy of High-Flow Nasal Cannula Therapy in Intensive Care Units

• Published in: Journal of intensive care medicine 2017-01, p.885066616689043-885066616689043
• Main Authors: Liesching, Timothy N, Lei, Yuxiu
• Format: Article
• Language: English
• ISSN: 1525-1489
• DOI: 10.1177/0885066616689043

We conducted a meta-analysis to compare the physiological and clinical outcomes of high-flow nasal cannula (HFNC) with standard oxygen (O ) or conventional noninvasive ventilation (NIV) in intensive care units (ICUs). We selected the full-text prospective studies comparing HFNC with standard O or NIV in ICU. The continuous variables were analyzed with sample size-adjusted pooled t test. The categorical variables were extracted and combined for recalculating odds ratio. We included 18 articles with 2004 patients. No difference was observed in the below outcomes comparing HFNC with standard O : oxygen saturation (95.0% vs 93.8%, P = .27), Pao /Fio (217.7 vs 161.9 mm Hg, P = .29), Paco (38.3 vs 39.3 mm Hg, P = .33), pH (7.416 vs 7.419, P = .90), discomfort (1.19 vs 1.44, P = .44), intubation or reintubation rate (odds ratio = 0.79, 95% confidence interval [CI]: 0.39-1.21, P = .27), and ICU stay (4.0 vs 4.5 days, P = .90). Below outcomes were modestly improved with HFNC compared to standard O : respiratory rate (21.6 vs 24.7, P = .06) and ICU mortality (odds ratio = 0.69, 95% CI: 0.43-1.11, P = .13). Below outcomes were significantly improved with HFNC compared to standard O : heart rate (89.1 vs 98.4, P = .03), Pao (104.5 vs 90.0 mm Hg, P = .04), and dyspnea (2.7 vs 4.3, P = .05). When comparing HFNC to NIV, below outcomes were significantly lower: Pao (106.9 vs 134.2 mm Hg, P = .02), Pao /Fio (178.4 vs 220.0 mm Hg, P = .02), Paco (37.7 vs 39.2 mm Hg, P = .04), and ICU mortality (odds ratio = 0.39, 95% CI: 0.19-0.82, P = .01). When comparing to standard O , the most effective outcomes from HFNC are reduced heart rate and dyspnea in both ICU and critical care unit patients. The HFNC modestly reduced intubation rate and ICU mortality. Patients with pneumonia may benefit from HFNC in reduced respiratory rate, heart rate, dyspnea, discomfort, intubation rate, ICU mortality, ICU stay, and improved Pao . When comparing to NIV, HFNC group did not do as good in Pao and Pao /Fio but had a slightly lower intubation rate and ICU mortality.